Perceptive Informatics Completes Over 500 System Integrations as the Biopharma Industry Continues to Adopt Seamless eClinical... ( BOSTON Dec.15 2011 /- As the bio...)

HOME >> MEDICINE >> TECHNOLOGY

Perceptive Informatics Completes Over 500 System Integrations as the Biopharma Industry Continues to Adopt Seamless eClinical Solutions

Date:12/15/2011

BOSTON, Dec.15, 2011 /PRNewswire/ -- As the biopharmaceutical industry continues to migrate toward the use of more seamless eClinical solutions to accelerate clinical development, Perceptive Informatics, a leading eClinical solutions provider and subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), has reached a milestone of completing more than 500 integration projects to connect disparate applications across clinical technology systems provided by multiple vendors. Perceptive's integration solutions are delivered by its dedicated eClinical Technology Services experts who have an in-depth understanding of advanced technologies, clinical development processes and validated system integrations.

"With standalone systems, the opportunity to maximally leverage technology has been extremely limited. The biopharmaceutical industry is moving toward using a more convergent solution, built on top of a common platform, as we've seen in the ERP software segment. Over the last few years and literally hundreds of integrations, we have begun to identify patterns and platform solutions that enable our customers to take advantage of technology in a more efficient and cost effective manner," said Nick Richards, Vice President, Product Management, Perceptive Informatics.

According to Mr. Richards, "At Perceptive, while we have been helping companies to integrate diverse applications, in parallel we have been investing in actively pursuing our vision to create a tightly woven ecosystem of solutions underpinned by a robust eClinical platform—to allow our customers to achieve new levels of collaboration, insights, and efficiencies. We continue to drive innovation to enable a shift in the way technologies are used in the biopharmaceutical industry. This has neve
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:6/18/2013)... 2013 New-generation electronic designs are focused ... lightweight. Simultaneously, circuitry is increasing the number of ... which it performs at. Connecting cables from the ... equipment, such as cameras or detectors, must be ... connectors include custom cable designs for high-quality signal ...

(Date:6/18/2013)... EMERYVILLE, Calif. , June 18, 2013 ... today from a Phase 2/3 clinical trial of ... statistically significant improvement in levodopa-induced dyskinesia (LID) as ... versus placebo in the Unified Dyskinesia Rating Scale ... amantadine intended for once-nightly administration that is being ...

(Date:6/18/2013)... 2013 Polymer Technology Systems, Inc. ... Group to integrate the CardioChek ® ... by health systems across the country. The CardioChek ... distributed through Hanson Medical Systems , offers ... LDL cholesterol, triglycerides, and glucose. (Logo: ...

Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6 Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2 Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3

[0] Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility [0] Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease [0] Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients

... /PRNewswire-Asia/ -- Neusoft Corporation ("Neusoft", 600718.SH), a leading ... announced that its wholly-owned subsidiary Neusoft Europe Inc. ... Aerotel Medical Systems Ltd. ("Aerotel"), a leading global ... and telecare solutions based in Israel, under which ...

... Leading events organiser UBM Live is today ... ICSE, P-MEC and BioPh Japan events in Tokyo as a ... have now been rescheduled and will be held from 13-15 ... business community is intent on picking itself up as quickly ...

Cached Medicine Technology:Neusoft to Invest in Israeli Medical Solutions Company for Accelerating Expansion in Global Healthcare Service Market 2 Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events 2 Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events 3

Neusoft to Invest in Israeli Medical Solutions Company for Accelerating Expansion in Global Healthcare Service Market Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events

(Date:6/18/2013)... Seven-year-old Riley Salz of Encino, California, is on ... hours a week of applied behavior analysis (ABA) therapy ... Autism and Related Disorders (CARD). Riley has been in ... remarkable progress, including learning to speak, starting conversations, making ... through autism is now featured in CARD’s “Mission Possible: ...

(Date:6/18/2013)... have launched an innovative clinical trial, unique in ... a patient,s own stem cells to prevent leg ... , Led by Vik Kashyap, MD, Division ... Center,s Harrington Heart & Vascular Institute and Professor ... of Medicine, the clinical trial is designed to ...

(Date:6/18/2013)... More than 1.1 million people in the U.S. ages 13 ... for Disease Control and Prevention (CDC). Of those, nearly 20 ... HIV Testing Day on June 27, Allsup, a nationwide provider ... CDC and other organizations are raising awareness of the importance ... new HIV infections each year. Along with developing AIDS, those ...

(Date:6/18/2013)... June 18, 2013 myCNAjobs announces the ... free downloads, articles, and tips to the Caregiver Resources ... care for the 10,000+ retiring baby boomers each day, ... caregiver job resources has never been greater. ... job community, recently launched the first-ever free resource ...

(Date:6/18/2013)... FL (PRWEB) June 18, 2013 A ... by storm. The burgeoning aquaculture industry is redefining the ... one of the most acclaimed personal culinary chefs on ... clientele on benefits of sustainable seafood and the promising ... in abundance these days. Many consumers strive to fully ...

Breaking Medicine News(10 mins):Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3 Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2 Health News:Allsup Observes National HIV Testing Day June 27 2 Health News:Allsup Observes National HIV Testing Day June 27 3 Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2 Health News:New $119 Million Industry Swimming Up the East Coast 2

[0] June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy [0] UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation [0] Allsup Observes National HIV Testing Day June 27 [0] myCNAjobs Adds New Resources to Growing Caregiver Career Center [0] New $119 Million Industry Swimming Up the East Coast

... When family members ask physicians not to disclose bad ... balance their obligation to be truthful to the patient ... harmful. To help clinicians more successfully manage these conflicts, ... in collaboration with colleagues at Stanford University, have developed ...

... Ellex Medical Lasers,Limited (ASX: ELX), a global ... and ultrasound systems, announced today that the initial,results ... will be presented by Peter Hamilton MD, FRCOph ... Ophthalmology, which takes place,November 10-13, in New Orleans. ...

... Inc. announced,completion of the company,s Phase 1 clinical ... for the treatment of inflammatory,diseases linked to the ... Phase 1 trial for AM803, a second oral ... AM103 and AM803 are novel inhibitors of 5-lipoxygenase-activiting,protein ...

... tool for 50% faster miRNA preparation with no,detectable large RNA ... ... developing area of RNAi, ST. LOUIS, Nov. 1 ... Kit,( http://www.sigma.com/mirna ) for purification of miRNA from diverse,biological sources. ...

... - 20% U.S. Sequential Quarterly Sales Increase ... - FY08 Revenue Projection Raised - ... - Conference Call to be Held at 10:00 a.m. Central Time Today -, ... million for the second quarter,of fiscal 2008 ended September 30, 2007, up 73% from $1.8 ...

... Sales up 11.2% and Earnings Per Diluted Share up 20% Excluding Tax Items ... ... Fourth Quarter - - Conference ... West Pharmaceutical,Services, Inc. (NYSE: WST ) today announced the results of operations for,the ...

Don't tell mother she has cancer Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter West Pharmaceutical Services Announces Third Quarter 2007 Results

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

Immunoglobulin G, CSF Immunoglobulin A, CSF Immunofixation Electrophoresis Gel Immunocytochemistry